🔗 Share this article

Texas Attorney General Paxton is taking legal action against the producers of acetaminophen, alleging the firms concealed alleged dangers that the drug created to pediatric neurological development.

The lawsuit follows four weeks after Former President Trump promoted an unverified association between consuming Tylenol - referred to as acetaminophen - while pregnant and autism spectrum disorder in children.

Paxton is suing the pharmaceutical giant, which formerly manufactured the medication, the only pain reliever suggested for women during pregnancy, and the current manufacturer, which currently produces it.

In a official comment, he said they "betrayed America by gaining financially from discomfort and marketing drugs regardless of the dangers."

The manufacturer asserts there is insufficient reliable data connecting acetaminophen to autism.

"These companies lied for decades, intentionally threatening millions to boost earnings," the attorney general, a Republican, stated.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the health of women and children in America."

On its website, the company also said it had "consistently assessed the relevant science and there is no credible data that demonstrates a proven link between using acetaminophen and autism."

Organizations acting on behalf of physicians and health professionals share this view.

ACOG has declared acetaminophen - the primary component in acetaminophen - is among limited choices for women during pregnancy to manage pain and elevated temperature, which can pose serious health risks if not addressed.

"In over twenty years of research on the utilization of acetaminophen in pregnancy, not a single reputable study has conclusively proven that the usage of acetaminophen in any stage of pregnancy results in neurological conditions in children," the group commented.

The court filing references recent announcements from the Trump administration in claiming the drug is reportedly hazardous.

Recently, Trump raised alarms from medical authorities when he advised women during pregnancy to "resist strongly" not to use acetaminophen when sick.

Federal regulators then released a statement that physicians should contemplate reducing the usage of acetaminophen, while also declaring that "a proven link" between the drug and autism in young ones has remains unverified.

The Health Department head Robert F Kennedy Jr, who supervises the Food and Drug Administration, had promised in spring to undertake "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a short period.

But experts advised that finding a sole reason of autism spectrum disorder - considered by experts to be the consequence of a complicated interplay of inherited and environmental factors - would not be simple.

Autism spectrum disorder is a type of enduring cognitive variation and condition that affects how people encounter and engage with the surroundings, and is identified using doctors' observations.

In his legal document, the attorney general - who supports Trump who is running for the Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism.

This legal action attempts to require the firms "remove any marketing or advertising" that states Tylenol is reliable for pregnant women.

The Texas lawsuit parallels the concerns of a collection of mothers and fathers of minors with autism spectrum disorder and ADHD who took legal action against the makers of Tylenol in two years ago.

The court rejected the lawsuit, declaring investigations from the plaintiffs' authorities was lacking definitive proof.